Fyrwald J Erik 4
4 · ELI LILLY & Co · Filed Aug 12, 2025
Insider Transaction Report
Form 4
Fyrwald J Erik
Director
Transactions
- Purchase
Common Stock
2025-08-12$642.59/sh+879$564,833→ 74,577.779 total - Purchase
Common Stock
2025-08-12$642.00/sh+686$440,409→ 73,698.779 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.